About Cardiologs
Cardiologs is a medical AI company that develops innovative software solutions for cardiology diagnostics, utilizing clinically validated artificial intelligence to help reduce the burden of ECG analysis. The company aims to make cardiology diagnostics scalable and accessible to everyone by providing tools for clinicians and service providers across the globe to face the increased demand for cardiological diagnosis. The company's flagship product, the Cardiologs Holter Platform, is the first FDA-cleared ECG analysis solution powered by deep learning technology. With over 20 publications and abstracts, four patents, and more than 200 million ECGs processed, the platform helps diagnose over two million patients per year. The technology leverages medical-grade AI to alleviate the burden of redundant ECG analysis tasks, enabling clinicians to save time and treat more patients. Cardiologs is now part of Philips, operating under the Philips Professional Healthcare division. The company's solutions are designed specifically for arrhythmia diagnostics, providing advisory support to physicians and clinicians in conjunction with their clinical knowledge and patient information. The platform has demonstrated significant impact, with customers reporting the ability to triple their Holter activity while delivering faster diagnoses to more patients.
Mission & Story
Mission
We aim to make cardiology diagnostics scalable and accessible to everyone
Clinical Focus
Medical conditions and clinical areas addressed by Cardiologs.
Who It Serves
Milestones & Awards
Recent Milestones
Acquired by Philips and integrated into Philips Professional Healthcare division
Awards & Recognition
First FDA-cleared ECG analysis solution powered by deep learning technology
Key Partnerships
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 64 →
AccurKardia
AI-powered platform for cardiovascular disease detection and cardiac risk assessment.
Acorai
AI platform for cardiovascular disease detection and cardiac risk assessment.
Aisap
11-50 employees
AISAP provides FDA-cleared AI-powered diagnostic algorithms embedded in an operating system for point-of-care ultrasound (POCUS) devices. The platform enables rapid, expert-level cardiac imaging interpretation at the bedside, helping physicians detect structural heart disease early and make faster clinical decisions across hospitals, clinics, and screening programs.
AliveCor
AliveCor develops FDA-cleared, AI-powered ECG devices and software platforms for cardiac monitoring. The company offers portable ECG solutions ranging from consumer personal devices to clinical-grade 12-lead systems, serving patients, healthcare providers, biopharma companies, and health systems with remote and connected cardiac care.
Anumana AI
series c · 175 employees
Anumana AI develops and delivers AI-driven ECG algorithms to enable early diagnosis and intervention for cardiovascular conditions.
Artrya
11-50 employees
Artrya develops AI-powered solutions for rapid assessment of chest pain patients in emergency and primary care settings. The company's technology analyzes coronary computed tomography angiography (CCTA) to detect arterial plaque and stratify patient risk within minutes.
Bay Labs
Bay Labs is a health AI company focused on cardiology and cardiovascular health. The company's website is currently under construction with limited public information available.
BunkerHill Health
Bunkerhill Health provides Carebricks, an AI-powered platform that enables health systems to design, deploy, and operationalize AI agents across clinical and operational workflows. The platform reasons across patient data and automates actions within existing EHR systems.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.